Skip to main content
  • Home
  • RoundTable Healthcare Partners
Institutional profile

RoundTable Healthcare Partners

RoundTable Healthcare Partners is an operating-oriented private equity firm focused exclusively on healthcare.

Official website

  • Healthcare and life sciences private equity investment firm
  • Healthcare & Life Sciences PEF
  • Tier III

Overview

RoundTable Healthcare Partners is an operating-oriented private equity firm focused exclusively on healthcare. Its principal sectors include medical products, specialty pharmaceuticals, healthcare distribution, and outsourced services.

The firm’s products-and-services orientation requires capabilities in manufacturing, quality systems, supply chains, distribution relationships, regulatory compliance, and commercial execution. These demands differ materially from those of provider-services investing. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.

Firm facts

InstitutionRoundTable Healthcare Partners
TypeHealthcare and life sciences private equity investment firm
HeadquartersLake Forest, United States
Founded2001
Primary ranking focusHealthcare & Life Sciences PEF
Highest 2026 tierTier III

Activities and investment capabilities

RoundTable supports portfolio companies through operational improvement, strategic expansion, and acquisition-led growth. Its long-standing healthcare-only model provides experience across economic, regulatory, and product cycles.

Healthcare investing

Equity investment across healthcare services, products and technology.

Life sciences exposure

Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.

Sector value creation

Support informed by regulation, reimbursement, clinical workflows and market access.

Strategy and transaction coverage

Strategy and sector coverage

Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT

Transaction and ownership contexts

Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions

Market position

RoundTable Healthcare Partners fits Tier III because it is a credible and enduring specialist with useful exposure to healthcare products and distribution, although its institutional footprint is more concentrated than that of the larger dedicated platforms.

RoundTable Healthcare Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

RoundTable Healthcare Partners is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through RoundTable Healthcare Partners’s official website.

Leadership areaCurrent source
Investment and operating leadershipCurrent team and governance information

Corporate and public information

This profile refers to RoundTable Healthcare Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.

Corporate and disclosure information
OrganizationRoundTable Healthcare Partners
HeadquartersLake Forest, United States
Public websiteroundtablehp.com
Profile basisPublic institutional information and Capital Ranking editorial research

Ranking recognition

Related Economy analysis

Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:

Sources

  1. RoundTable Healthcare Partners — official website
  2. Capital Ranking — Top 30 Healthcare & Life Sciences PEF 2026

First published: 28 August 2026

Last reviewed: 28 August 2026

Profile scope: Healthcare & Life Sciences PEF

This page is an editorial reference and does not constitute investment, legal or regulatory advice.